D James Bidzos, Director, Executive Chairman, President, & CEO, on June 02, 2026, sold 3,300 shares in Verisign (VRSN) for $981,646. Following the Form 4 filing with the SEC, Bidzos has control over a total of 439,339 common shares of the company, with 439,339 shares held directly.
SEC Filing:
Werner Edward Cooper, Chief Financial Officer, on June 02, 2026, sold 2,500 shares in F5 (FFIV) for $1,000,000. Following the Form 4 filing with the SEC, Werner Edward Cooper has control over a total of 406 common shares of the company, with 406 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1048695/000204264726000012/xslF345X05/wk-form4_1780522311.xml
Spencer R Berthelsen, Director, on June 01, 2026, sold 8,000 shares in Ionis Pharmaceuticals (IONS) for $605,360. Following the Form 4 filing with the SEC, Berthelsen has control over a total of 156,083 common shares of the company, with 156,013 shares held directly and 70 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/874015/000087401526000188/xslF345X05/edgardoc.xml
David A Lorber, 10% Owner, Director, Chairman and CEO, on June 01, 2026, executed a purchase for 8,656 shares in Phenixfin (PFX) for $389,605. Following the Form 4 filing with the SEC, Lorber has control over a total of 257,232 common shares of the company, with 253,854 shares held directly and 3,378 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1490349/000121390026064840/xslF345X05/ownership.xml